Comparison of Analgesic Efficiency Between Serratus Block and Paravertebral Block in Video-assisted Thoracic Surgery. Double-blind Randomized Comparative Non-inferiority Study (BSBP)

Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04983836
Collaborator
(none)
150
1
2
13
11.6

Study Details

Study Description

Brief Summary

Currently, the 2 main techniques of regional loco anesthesia in perioperative analgesic management of the thoracotomy remains the establishment of a thoracic epidural or paravertebral block. On the other hand, there is no standard of perioperative analgesic management in the case of thoracic surgery under video-thoracoscopy. The video-thoracoscopy, by its mini-invasive character, makes the levels of pain lower in post-operative questioning the benefit/risk balance of the paravertebral block. In 2013, Blanco published a new technique of locoregional anesthesia called the block Serratus allowing analgesia of a homolateral thorax hemi The latter by its simplicity of realization and its lesser risk is growing in thoracic surgery. This pilot study finds an equivalence in total oxycodone consumption in the first 2 post-operative days with a number of complications related to the serratus block lower than the serratus block compared to the paravertebral block in preoperative surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Serratus anesthesia technique
  • Procedure: Paravertebral anesthesia technique
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective, comparative, monocentric, randomized non-inferiority interventional study, in double-blind.Prospective, comparative, monocentric, randomized non-inferiority interventional study, in double-blind.
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Comparison of Analgesic Efficiency Between Serratus Block and Paravertebral Block in Video-assisted Thoracic Surgery. Double-blind Randomized Comparative Non-inferiority Study
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Serratus Block

Procedure: Serratus anesthesia technique
locoregional anaesthesia allowing analgesia of the hemi-thorax by ultrasound guided single injection of naropeine 5mg/ml

Other: Paravertebral Block

Procedure: Paravertebral anesthesia technique
Ultrasound guided single injection of of naropeine 5mg/ml dose into the paravertebral space next to the thoracic spine

Outcome Measures

Primary Outcome Measures

  1. Pain evaluation [48 hours after the surgery]

    Assess the non-inferiority of the single-injection echo-guided serratus block, performed in video-thoracic surgery preoperative, on the post-operative mean pain during the first 48 hours, compared to the single-injection echo-guided paravertebral block with a simple numeric scale (from 0 to 10)

Secondary Outcome Measures

  1. Walking test [24 hours after the surgery]

    Improvement of walking distance during the test at 6 min post-operative

  2. Post operative morphine dose Post operative administrated morphin dose [48 hours after the surgery]

    Mesure of intraoperative morphine administrated dose and total morphine administrated dose (in mg).

  3. Morphine side effect quantification [48 hours after the surgery]

    Collection of adverse reactions due to morphine administration (nausea, vomiting, pruritus, urine retention, respiratory depression)

  4. Length of hospitalisation duration [1 year]

    Number of hospitalisation days

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years

  • Patient who has given their free, informed and signed consent

  • Social security affiliation;

Exclusion Criteria:
  • pregnant woman

  • guardianship / curatorship / private patient under public law

  • surgery to be performed urgently (less than 24 hours)

  • surgery redux

  • thoracotomy surgery

  • sternotomy surgery

  • pleurectomy

  • patient participating simultaneously in another research that may interfere with results of the study

  • severe abnormality of haemostasis (80,000/ml platelets) and/or coagulation (TP 50%, factor V 50%).

  • Prior use of morphine;

  • chronic pain/chest neuropathies

  • sepsis

  • patients with insulin-dependent diabetes and/or diabetic neuropathy.

  • severe kidney or liver failure.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de NICE Nice Toutes France 06000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nice

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT04983836
Other Study ID Numbers:
  • 19-AOI-04
First Posted:
Jul 30, 2021
Last Update Posted:
Jul 30, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 30, 2021